Mitsui Global Investment — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Ellipsis Health builds Sage, an AI voice agent designed to support healthcare organizations by handling patient interactions and expanding clinical capacity.
AI & Machine LearningDigital HealthHealthtechSan Francisco, US
Mainul Islam(Executive Officer, Director)Mainul Mondal(Founder)inMichael Aratow(Co-Founder & Chief Medical Officer)in
BoardMarie Hurabiell(Director)
Co-investorsAble PartnersAIX VenturesAlumni VenturesAwareness VentureCity LightCVS Health Ventures+8 more
Stately Bio develops stem cell-derived regenerative and cell therapies using a machine learning platform that measures cell identity, behavior, and maturation directly from live-cell, label-free imaging.
AI & Machine LearningBiotechMedical Devices
Frank Li(Founder & CEO)Christian Elabd, PhD(Head of Biology)
Co-investorsAIX VenturesFoothill VenturesAxial VCBoxOne VenturesCaffeinated CapitalDimension Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.








